Heinz Christoph Maeusli
CIK 1788919 · last filed 2026-05-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.08M
Companies
2
Total Filings
23
Lifetime Open-Market Net
-$1.31M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LNTH | Director | 30,014 | $102.64 | $3.08M | -$1.31M | 19 | 2026-05-18 |
| PROGENICS PHARMACEUTICALS INC (PGNX) Delisted | Director | — | — | — | $0 | 2 | 2019-12-17 |
Recent Filings · Page 2 of 3
23 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-03-02 | LNTH | Buy (P) | +1,000 | $18.0K | EDGAR |
| 2021-02-23 | LNTH | Buy (P) | +1,000 | $19.4K | EDGAR |
| 2021-02-17 | LNTH | Buy (P) | +1,000 | $20.0K | EDGAR |
| 2021-02-09 | LNTH | Buy (P) | +1,000 | $17.9K | EDGAR |
| 2021-02-02 | LNTH | Buy (P) | +1,000 | $16.1K | EDGAR |
| 2021-01-26 | LNTH | Buy (P) | +1,000 | $15.3K | EDGAR |
| 2021-01-20 | LNTH | Buy (P) | +1,000 | $15.8K | EDGAR |
| 2020-10-05 | LNTH | Grant (A) | +1,308 | $0 | EDGAR |
| 2020-08-12 | LNTH | Grant (A) | +922 | $0 | EDGAR |
| 2020-06-23 | — | Disp (D) | — | $0 |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.